Healthcare entity

European Medicines Agency (EMA)

Company

Every one of those 2 sits in a single category, regulation. European Medicines Agency (EMA) is most often covered alongside Biogen, which appears in 1 of these 2 stories. Across a 47-day span, the pace is roughly 0.3 stories per week.

Last mentioned: Aug 3, 2026

Entity pulse

Recent coverage · European Medicines Agency (EMA)

2 stories
6 avg impact
50% positive
0% negative

Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 50 percentage points.

  • 50% positive
  • 50% neutral

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about European Medicines Agency (EMA)

Every one of those 2 sits in a single category, regulation. European Medicines Agency (EMA) is most often covered alongside Biogen, which appears in 1 of these 2 stories. Across a 47-day span, the pace is roughly 0.3 stories per week. They are less corroborated than the beat average, carrying 2 original sources each against 4.9 for the same window. At 6, the average consequence score sits below the same-window beat average of 6.3. We currently track 2 Healthcare stories that mention European Medicines Agency (EMA), published between June 18, 2026 and August 3, 2026.

Stories tracked
2
Per week
0.3
Sources per story
2

Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 282 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering European Medicines Agency (EMA). Shared-story counts are live from our verified record — not editorial picks.

Stories mentioning European Medicines Agency (EMA) 2

Health Policy Positive

4th EMA GMP Win Clears 19 Biologics for EU Patients

WuXi Biologics' Suzhou facility earned its fourth EMA GMP certificate with zero findings, paving the way for 19 biologic therapies to reach European patients. This achievement reinforces the critical role of rigorous biosafety testing in safeguarding the global healthcare supply chain.

2 sources

European Medicines Agency (EMA) is linked from 2 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.